Answers are grounded in this paper and cite their sources.
We treated a patient with type 2 diabetes suffering from chronic venous and neuro-ischemic wounds not healing under standard care with local application of autologous bone marrow cells (mBMC) isolated from bone marrow aspirate. This procedure led to a reduction of wound size, a markedly increased vascularization and infiltration of mononuclear cells, 7 days after treatment, without any signs of a systemic reaction to treatment. Locally applied mBMC could, therefore, provide a treatment option in end stage diabetic wound healing disorders.
No takes yet. Share an insight, caveat, or question.
Humpert et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: